These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29673622)

  • 1. Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective Study.
    Tachibana T; Andou T; Tanaka M; Ito S; Miyazaki T; Ishii Y; Ogusa E; Koharazawa H; Takahashi H; Motohashi K; Aoki J; Nakajima Y; Matsumoto K; Hagihara M; Hashimoto C; Taguchi J; Fujimaki K; Fujita H; Fujisawa S; Kanamori H; Nakajima H;
    Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):415-421. PubMed ID: 29673622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AML: high serum ferritin at initial diagnosis has a negative impact on long-term survival.
    Ihlow J; Gross S; Sick A; Schneider T; Flörcken A; Burmeister T; Türkmen S; Arnold R; Dörken B; Westermann J
    Leuk Lymphoma; 2019 Jan; 60(1):69-77. PubMed ID: 29846127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia.
    Bertoli S; Paubelle E; Bérard E; Saland E; Thomas X; Tavitian S; Larcher MV; Vergez F; Delabesse E; Sarry A; Huguet F; Larrue C; Bosc C; Farge T; Sarry JE; Michallet M; Récher C
    Eur J Haematol; 2019 Feb; 102(2):131-142. PubMed ID: 30325535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center.
    Jaime-Pérez JC; Padilla-Medina JR; Fernández LT; Herrera-Garza JL; Gutiérrez-Aguirre CH; Tarín-Arzaga L; Gómez-Almaguer D
    Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):286-292. PubMed ID: 29478946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes.
    Artz AS; Logan B; Zhu X; Akpek G; Bufarull RM; Gupta V; Lazarus HM; Litzow M; Loren A; Majhail NS; Maziarz RT; McCarthy P; Popat U; Saber W; Spellman S; Ringden O; Wickrema A; Pasquini MC; Cooke KR;
    Haematologica; 2016 Nov; 101(11):1426-1433. PubMed ID: 27662010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
    Pfrepper C; Klink A; Behre G; Schenk T; Franke GN; Jentzsch M; Schwind S; Al-Ali HK; Hochhaus A; Niederwieser D; Sayer HG
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):317-24. PubMed ID: 26424692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Platelet Counts at Diagnosis Predict Better Survival for Patients with Intermediate-Risk Acute Myeloid Leukemia.
    Zhang Y; Gu H; Chen Q; Zhang Y; Cheng H; Yang J; Wang J; Hu X
    Acta Haematol; 2020; 143(1):9-18. PubMed ID: 31167182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.
    Quarello P; Fagioli F; Basso G; Putti MC; Berger M; Luciani M; Rizzari C; Menna G; Masetti R; Locatelli F
    Br J Haematol; 2015 Nov; 171(4):566-73. PubMed ID: 26223157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
    Lim ZY; Fiaccadori V; Gandhi S; Hayden J; Kenyon M; Ireland R; Marsh J; Ho AY; Mufti GJ; Pagliuca A
    Leuk Res; 2010 Jun; 34(6):723-7. PubMed ID: 19944463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia.
    Heini AD; Hugo R; Berger MD; Novak U; Bacher U; Pabst T
    Hematol Oncol; 2020 Feb; 38(1):74-81. PubMed ID: 31755141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.
    Chen X; Xie H; Wood BL; Walter RB; Pagel JM; Becker PS; Sandhu VK; Abkowitz JL; Appelbaum FR; Estey EH
    J Clin Oncol; 2015 Apr; 33(11):1258-64. PubMed ID: 25732155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT.
    Canaani J; Labopin M; Socié G; Nihtinen A; Huynh A; Cornelissen J; Deconinck E; Gedde-Dahl T; Forcade E; Chevallier P; Bourhis JH; Blaise D; Mohty M; Nagler A
    Am J Hematol; 2017 Jul; 92(7):653-659. PubMed ID: 28370339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
    Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
    Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of A-kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia.
    Yan Y; Li X; Gao J
    J Clin Lab Anal; 2020 May; 34(5):e23055. PubMed ID: 32356617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
    Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-treatment blood inflammatory markers as predictors of systemic infection during induction chemotherapy: results of an exploratory study in patients with acute myeloid leukemia.
    Hong J; Woo HS; Ahn HK; Sym SJ; Park J; Cho EK; Shin DB; Lee JH
    Support Care Cancer; 2016 Jan; 24(1):187-194. PubMed ID: 25980681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
    Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
    Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Baron F; Labopin M; Peniket A; Jindra P; Afanasyev B; Sanz MA; Deconinck E; Nagler A; Mohty M
    Cancer; 2015 Apr; 121(7):1048-55. PubMed ID: 25424330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia.
    Colovic N; Tomin D; Vidovic A; Suvajdzic N; Jankovic G; Palibrk V; Djunic I; Djurasinovic V; Virijevic M
    Biomed Pharmacother; 2012 Dec; 66(8):578-82. PubMed ID: 23085253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC protein expression is an important prognostic factor in acute myeloid leukemia.
    Ohanian M; Rozovski U; Kanagal-Shamanna R; Abruzzo LV; Loghavi S; Kadia T; Futreal A; Bhalla K; Zuo Z; Huh YO; Post SM; Ruvolo P; Garcia-Manero G; Andreeff M; Kornblau S; Borthakur G; Hu P; Medeiros LJ; Takahashi K; Hornbaker MJ; Zhang J; Nogueras-González GM; Huang X; Verstovsek S; Estrov Z; Pierce S; Ravandi F; Kantarjian HM; Bueso-Ramos CE; Cortes JE
    Leuk Lymphoma; 2019 Jan; 60(1):37-48. PubMed ID: 29741984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.